Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 326 entries
Sorted by: Best Match Show Resources per page
Dynamic scaling behavior of a growing self-affine fractal interface in a paper-towel-wetting experiment.

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics

Hopkins AE, Kwon TH, O'Donnell SE.
PMID: 9965116
Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1996 Jul;54(1):685-690. doi: 10.1103/physreve.54.685.

No abstract available.

Cite
Hopkins AE, Kwon TH, O'Donnell SE. Dynamic scaling behavior of a growing self-affine fractal interface in a paper-towel-wetting experiment. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1996;54(1):685-690doi: 10.1103/physreve.54.685.
Hopkins, A. E., Kwon, T. H., & O'Donnell, S. E. (1996). Dynamic scaling behavior of a growing self-affine fractal interface in a paper-towel-wetting experiment. Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics, 54(1), 685-690. https://doi.org/10.1103/physreve.54.685
Hopkins, et al. "Dynamic scaling behavior of a growing self-affine fractal interface in a paper-towel-wetting experiment." Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics vol. 54,1 (1996): 685-690. doi: https://doi.org/10.1103/physreve.54.685
Hopkins AE, Kwon TH, O'Donnell SE. Dynamic scaling behavior of a growing self-affine fractal interface in a paper-towel-wetting experiment. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1996 Jul;54(1):685-690. doi: 10.1103/physreve.54.685. PMID: 9965116.
Copy Download .nbib Format: NLM
The substantial burden of non-communicable diseases and HIV-comorbidity amongst adults: Screening results from an integrated HIV testing services clinic for adults in Soweto, South Africa.

EClinicalMedicine

Hopkins KL, Hlongwane KE, Otwombe K, Dietrich J, Cheyip M, Olivier J, van Rooyen H, Doherty T, Gray GE.
PMID: 34308316
EClinicalMedicine. 2021 Jul 14;38:101015. doi: 10.1016/j.eclinm.2021.101015. eCollection 2021 Aug.

BACKGROUND: South Africa is disproportionately impacted by non-communicable diseases (NCDs) and HIV/AIDS. We investigated the prevalence of known/unknown NCD risk factors, HIV, and NCD risk factor-HIV comorbidity; and treatment status on known diseases to determine the prevalence of controlled/uncontrolled...

Cite
Hopkins KL, Hlongwane KE, Otwombe K, et al. The substantial burden of non-communicable diseases and HIV-comorbidity amongst adults: Screening results from an integrated HIV testing services clinic for adults in Soweto, South Africa. EClinicalMedicine. 2021;38:101015doi: 10.1016/j.eclinm.2021.101015.
Hopkins, K. L., Hlongwane, K. E., Otwombe, K., Dietrich, J., Cheyip, M., Olivier, J., van Rooyen, H., Doherty, T., & Gray, G. E. (2021). The substantial burden of non-communicable diseases and HIV-comorbidity amongst adults: Screening results from an integrated HIV testing services clinic for adults in Soweto, South Africa. EClinicalMedicine, 38101015. https://doi.org/10.1016/j.eclinm.2021.101015
Hopkins, Kathryn L, et al. "The substantial burden of non-communicable diseases and HIV-comorbidity amongst adults: Screening results from an integrated HIV testing services clinic for adults in Soweto, South Africa." EClinicalMedicine vol. 38 (2021): 101015. doi: https://doi.org/10.1016/j.eclinm.2021.101015
Hopkins KL, Hlongwane KE, Otwombe K, Dietrich J, Cheyip M, Olivier J, van Rooyen H, Doherty T, Gray GE. The substantial burden of non-communicable diseases and HIV-comorbidity amongst adults: Screening results from an integrated HIV testing services clinic for adults in Soweto, South Africa. EClinicalMedicine. 2021 Jul 14;38:101015. doi: 10.1016/j.eclinm.2021.101015. eCollection 2021 Aug. PMID: 34308316; PMCID: PMC8283339.
Copy Download .nbib Format: NLM
Patients' Perspectives on Qualitative Olfactory Dysfunction: Thematic Analysis of Social Media Posts.

JMIR formative research

Parker JK, Kelly CE, Smith BC, Kirkwood AF, Hopkins C, Gane S.
PMID: 34904953
JMIR Form Res. 2021 Dec 14;5(12):e29086. doi: 10.2196/29086.

BACKGROUND: The impact of qualitative olfactory disorders is underestimated. Parosmia, the distorted perception of familiar odors, and phantosmia, the experience of odors in the absence of a stimulus, can arise following postinfectious anosmia, and the incidences of both have...

Cite
Parker JK, Kelly CE, Smith BC, et al. Patients' Perspectives on Qualitative Olfactory Dysfunction: Thematic Analysis of Social Media Posts. JMIR Form Res. 2021;5(12):e29086doi: 10.2196/29086.
Parker, J. K., Kelly, C. E., Smith, B. C., Kirkwood, A. F., Hopkins, C., & Gane, S. (2021). Patients' Perspectives on Qualitative Olfactory Dysfunction: Thematic Analysis of Social Media Posts. JMIR formative research, 5(12), e29086. https://doi.org/10.2196/29086
Parker, Jane K, et al. "Patients' Perspectives on Qualitative Olfactory Dysfunction: Thematic Analysis of Social Media Posts." JMIR formative research vol. 5,12 (2021): e29086. doi: https://doi.org/10.2196/29086
Parker JK, Kelly CE, Smith BC, Kirkwood AF, Hopkins C, Gane S. Patients' Perspectives on Qualitative Olfactory Dysfunction: Thematic Analysis of Social Media Posts. JMIR Form Res. 2021 Dec 14;5(12):e29086. doi: 10.2196/29086. PMID: 34904953; PMCID: PMC8673716.
Copy Download .nbib Format: NLM
Mepolizumab for chronic rhinosinusitis with nasal polyps: treatment efficacy by comorbidity and blood eosinophil count.

The Journal of allergy and clinical immunology

Bachert C, Sousa AR, Han JK, Schlosser RJ, Sowerby LJ, Hopkins C, Maspero JF, Smith SG, Kante O, Karidi-Andrioti DE, Mayer B, Chan RH, Yancey SW, Chaker AM.
PMID: 35007624
J Allergy Clin Immunol. 2022 Jan 07; doi: 10.1016/j.jaci.2021.10.040. Epub 2022 Jan 07.

BACKGROUND: In the Phase III SYNAPSE study, mepolizumab reduced nasal polyp (NP) size and nasal obstruction in chronic rhinosinusitis with NP (CRSwNP).OBJECTIVE: To assess the efficacy of mepolizumab in patients from SYNAPSE grouped by comorbid asthma, aspirin-exacerbated respiratory disease...

Cite
Bachert C, Sousa AR, Han JK, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps: treatment efficacy by comorbidity and blood eosinophil count. J Allergy Clin Immunol. 2022;doi: 10.1016/j.jaci.2021.10.040.
Bachert, C., Sousa, A. R., Han, J. K., Schlosser, R. J., Sowerby, L. J., Hopkins, C., Maspero, J. F., Smith, S. G., Kante, O., Karidi-Andrioti, D. E., Mayer, B., Chan, R. H., Yancey, S. W., & Chaker, A. M. (2022). Mepolizumab for chronic rhinosinusitis with nasal polyps: treatment efficacy by comorbidity and blood eosinophil count. The Journal of allergy and clinical immunology, . https://doi.org/10.1016/j.jaci.2021.10.040
Bachert, Claus, et al. "Mepolizumab for chronic rhinosinusitis with nasal polyps: treatment efficacy by comorbidity and blood eosinophil count." The Journal of allergy and clinical immunology vol. (2022). doi: https://doi.org/10.1016/j.jaci.2021.10.040
Bachert C, Sousa AR, Han JK, Schlosser RJ, Sowerby LJ, Hopkins C, Maspero JF, Smith SG, Kante O, Karidi-Andrioti DE, Mayer B, Chan RH, Yancey SW, Chaker AM. Mepolizumab for chronic rhinosinusitis with nasal polyps: treatment efficacy by comorbidity and blood eosinophil count. J Allergy Clin Immunol. 2022 Jan 07; doi: 10.1016/j.jaci.2021.10.040. Epub 2022 Jan 07. PMID: 35007624.
Copy Download .nbib Format: NLM
Retraction: Neurogenic skeletal myopathy in patients with primary cardiomyopathy.

Circulation

Nutter DO, Hopkins LC, Heymsfield SB.
PMID: 6399694
Circulation. 1984 Jan;69(1):202. doi: 10.1161/01.cir.69.1.202.

No abstract available.

Cite
Nutter DO, Hopkins LC, Heymsfield SB. Retraction: Neurogenic skeletal myopathy in patients with primary cardiomyopathy. Circulation. 1984;69(1):202doi: 10.1161/01.cir.69.1.202.
Nutter, D. O., Hopkins, L. C., & Heymsfield, S. B. (1984). Retraction: Neurogenic skeletal myopathy in patients with primary cardiomyopathy. Circulation, 69(1), 202. https://doi.org/10.1161/01.cir.69.1.202
Nutter, D O, et al. "Retraction: Neurogenic skeletal myopathy in patients with primary cardiomyopathy." Circulation vol. 69,1 (1984): 202. doi: https://doi.org/10.1161/01.cir.69.1.202
Nutter DO, Hopkins LC, Heymsfield SB. Retraction: Neurogenic skeletal myopathy in patients with primary cardiomyopathy. Circulation. 1984 Jan;69(1):202. doi: 10.1161/01.cir.69.1.202. PMID: 6399694.
Copy Download .nbib Format: NLM
A Reduced Self-Positive Belief Underpins Greater Sensitivity to Negative Evaluation in Socially Anxious Individuals.

Computational psychiatry (Cambridge, Mass.)

Hopkins AK, Dolan R, Button KS, Moutoussis M.
PMID: 34212077
Comput Psychiatr. 2021 Apr 28;5(1):21-37. doi: 10.5334/cpsy.57.

Positive self-beliefs are important for well-being, and are influenced by how others evaluate us during social interactions. Mechanistic accounts of self-beliefs have mostly relied on associative learning models. These account for choice behaviour but not for the explicit beliefs...

Cite
Hopkins AK, Dolan R, Button KS, et al. A Reduced Self-Positive Belief Underpins Greater Sensitivity to Negative Evaluation in Socially Anxious Individuals. Comput Psychiatr. 2021;5(1):21-37doi: 10.5334/cpsy.57.
Hopkins, A. K., Dolan, R., Button, K. S., & Moutoussis, M. (2021). A Reduced Self-Positive Belief Underpins Greater Sensitivity to Negative Evaluation in Socially Anxious Individuals. Computational psychiatry (Cambridge, Mass.), 5(1), 21-37. https://doi.org/10.5334/cpsy.57
Hopkins, Alexandra K, et al. "A Reduced Self-Positive Belief Underpins Greater Sensitivity to Negative Evaluation in Socially Anxious Individuals." Computational psychiatry (Cambridge, Mass.) vol. 5,1 (2021): 21-37. doi: https://doi.org/10.5334/cpsy.57
Hopkins AK, Dolan R, Button KS, Moutoussis M. A Reduced Self-Positive Belief Underpins Greater Sensitivity to Negative Evaluation in Socially Anxious Individuals. Comput Psychiatr. 2021 Apr 28;5(1):21-37. doi: 10.5334/cpsy.57. PMID: 34212077; PMCID: PMC7611100.
Copy Download .nbib Format: NLM
Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis.

The Laryngoscope

Han JK, Bachert C, Lee SE, Hopkins C, Heffler E, Hellings PW, Peters AT, Kamat S, Whalley D, Qin S, Nelson L, Siddiqui S, Khan AH, Li Y, Mannent LP, Guillemin I, Chuang CC.
PMID: 34850966
Laryngoscope. 2022 Feb;132(2):265-271. doi: 10.1002/lary.29888. Epub 2021 Dec 01.

OBJECTIVES/HYPOTHESIS: Clinical trials of biologics to treat chronic rhinosinusitis with nasal polyposis (CRSwNP) have evaluated objective outcomes (e.g., University of Pennsylvania Smell Identification Test [UPSIT], nasal polyps score [NPS], and computed tomography Lund-Mackay score [CT-LMK]) and patient-reported symptoms (e.g.,...

Cite
Han JK, Bachert C, Lee SE, et al. Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis. Laryngoscope. 2021;132(2):265-271doi: 10.1002/lary.29888.
Han, J. K., Bachert, C., Lee, S. E., Hopkins, C., Heffler, E., Hellings, P. W., Peters, A. T., Kamat, S., Whalley, D., Qin, S., Nelson, L., Siddiqui, S., Khan, A. H., Li, Y., Mannent, L. P., Guillemin, I., & Chuang, C. C. (2022). Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis. The Laryngoscope, 132(2), 265-271. https://doi.org/10.1002/lary.29888
Han, Joseph K, et al. "Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis." The Laryngoscope vol. 132,2 (2022): 265-271. doi: https://doi.org/10.1002/lary.29888
Han JK, Bachert C, Lee SE, Hopkins C, Heffler E, Hellings PW, Peters AT, Kamat S, Whalley D, Qin S, Nelson L, Siddiqui S, Khan AH, Li Y, Mannent LP, Guillemin I, Chuang CC. Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis. Laryngoscope. 2022 Feb;132(2):265-271. doi: 10.1002/lary.29888. Epub 2021 Dec 01. PMID: 34850966.
Copy Download .nbib Format: NLM
An institution-wide tracheostomy rounding team: Initial caregiver perceptions.

American journal of otolaryngology

Quinton BA, Tierney WS, Bryson PC, Bribriesco A, Gillespie CT, Hopkins BD.
PMID: 34991021
Am J Otolaryngol. 2021 Dec 29;43(2):103367. doi: 10.1016/j.amjoto.2021.103367. Epub 2021 Dec 29.

PURPOSE: To analyze and present the initial findings of provider perceptions regarding the impact of the implementation of a hospital-wide Tracheostomy Rounding Team (TRT) on the delivery of tracheostomy care at the Cleveland Clinic.MATERIALS AND METHODS: Based on prior...

Cite
Quinton BA, Tierney WS, Bryson PC, et al. An institution-wide tracheostomy rounding team: Initial caregiver perceptions. Am J Otolaryngol. 2021;43(2):103367doi: 10.1016/j.amjoto.2021.103367.
Quinton, B. A., Tierney, W. S., Bryson, P. C., Bribriesco, A., Gillespie, C. T., & Hopkins, B. D. (2021). An institution-wide tracheostomy rounding team: Initial caregiver perceptions. American journal of otolaryngology, 43(2), 103367. https://doi.org/10.1016/j.amjoto.2021.103367
Quinton, Brooke A, et al. "An institution-wide tracheostomy rounding team: Initial caregiver perceptions." American journal of otolaryngology vol. 43,2 (2021): 103367. doi: https://doi.org/10.1016/j.amjoto.2021.103367
Quinton BA, Tierney WS, Bryson PC, Bribriesco A, Gillespie CT, Hopkins BD. An institution-wide tracheostomy rounding team: Initial caregiver perceptions. Am J Otolaryngol. 2021 Dec 29;43(2):103367. doi: 10.1016/j.amjoto.2021.103367. Epub 2021 Dec 29. PMID: 34991021.
Copy Download .nbib Format: NLM
Role of Extracellular Vesicle-Derived Biomarkers in Drug Metabolism and Disposition.

Drug metabolism and disposition: the biological fate of chemicals

Useckaite Z, Rodrigues AD, Hopkins AM, Newman LA, Johnson J, Sorich MJ, Rowland A.
PMID: 34353847
Drug Metab Dispos. 2021 Nov;49(11):961-971. doi: 10.1124/dmd.121.000411. Epub 2021 Aug 05.

Extracellular vesicles (EVs) are small, nonreplicating, lipid-encapsulated particles that contain a myriad of protein and nucleic acid cargo derived from their tissue of origin. The potential role of EV-derived biomarkers to the study of drug metabolism and disposition (DMD)...

Cite
Useckaite Z, Rodrigues AD, Hopkins AM, et al. Role of Extracellular Vesicle-Derived Biomarkers in Drug Metabolism and Disposition. Drug Metab Dispos. 2021;49(11):961-971doi: 10.1124/dmd.121.000411.
Useckaite, Z., Rodrigues, A. D., Hopkins, A. M., Newman, L. A., Johnson, J., Sorich, M. J., & Rowland, A. (2021). Role of Extracellular Vesicle-Derived Biomarkers in Drug Metabolism and Disposition. Drug metabolism and disposition: the biological fate of chemicals, 49(11), 961-971. https://doi.org/10.1124/dmd.121.000411
Useckaite, Zivile, et al. "Role of Extracellular Vesicle-Derived Biomarkers in Drug Metabolism and Disposition." Drug metabolism and disposition: the biological fate of chemicals vol. 49,11 (2021): 961-971. doi: https://doi.org/10.1124/dmd.121.000411
Useckaite Z, Rodrigues AD, Hopkins AM, Newman LA, Johnson J, Sorich MJ, Rowland A. Role of Extracellular Vesicle-Derived Biomarkers in Drug Metabolism and Disposition. Drug Metab Dispos. 2021 Nov;49(11):961-971. doi: 10.1124/dmd.121.000411. Epub 2021 Aug 05. PMID: 34353847.
Copy Download .nbib Format: NLM
50 years of radiotherapy research: Evolution, trends and lessons for the future.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Berger T, Noble DJ, Shelley LEA, Hopkins KI, McLaren DB, Burnet NG, Nailon WH.
PMID: 34619236
Radiother Oncol. 2021 Dec;165:75-86. doi: 10.1016/j.radonc.2021.09.026. Epub 2021 Oct 04.

Rapid and relentless technological advances in an ever-more globalized world have shaped the field of radiation oncology in which we practise today. These developments have drastically modified the habitus

Cite
Berger T, Noble DJ, Shelley LEA, et al. 50 years of radiotherapy research: Evolution, trends and lessons for the future. Radiother Oncol. 2021;165:75-86doi: 10.1016/j.radonc.2021.09.026.
Berger, T., Noble, D. J., Shelley, L. E. A., Hopkins, K. I., McLaren, D. B., Burnet, N. G., & Nailon, W. H. (2021). 50 years of radiotherapy research: Evolution, trends and lessons for the future. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 16575-86. https://doi.org/10.1016/j.radonc.2021.09.026
Berger, Thomas, et al. "50 years of radiotherapy research: Evolution, trends and lessons for the future." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 165 (2021): 75-86. doi: https://doi.org/10.1016/j.radonc.2021.09.026
Berger T, Noble DJ, Shelley LEA, Hopkins KI, McLaren DB, Burnet NG, Nailon WH. 50 years of radiotherapy research: Evolution, trends and lessons for the future. Radiother Oncol. 2021 Dec;165:75-86. doi: 10.1016/j.radonc.2021.09.026. Epub 2021 Oct 04. PMID: 34619236.
Copy Download .nbib Format: NLM
Enhanced Bellmunt Risk Score for Survival Prediction in Urothelial Carcinoma Treated With Immunotherapy.

Clinical genitourinary cancer

Abuhelwa AY, Bellmunt J, Kichenadasse G, McKinnon RA, Rowland A, Sorich MJ, Hopkins AM.
PMID: 34953754
Clin Genitourin Cancer. 2021 Dec 02; doi: 10.1016/j.clgc.2021.11.010. Epub 2021 Dec 02.

INTRODUCTION: The discrimination performance of Bellmunt risk score for immune checkpoint inhibitor (ICI) therapy is largely unknown. This study aimed to validate and enhance discrimination of the Bellmunt score in patients with urothelial carcinoma treated with ICIs.PATIENTS AND METHODS:...

Cite
Abuhelwa AY, Bellmunt J, Kichenadasse G, et al. Enhanced Bellmunt Risk Score for Survival Prediction in Urothelial Carcinoma Treated With Immunotherapy. Clin Genitourin Cancer. 2021;doi: 10.1016/j.clgc.2021.11.010.
Abuhelwa, A. Y., Bellmunt, J., Kichenadasse, G., McKinnon, R. A., Rowland, A., Sorich, M. J., & Hopkins, A. M. (2021). Enhanced Bellmunt Risk Score for Survival Prediction in Urothelial Carcinoma Treated With Immunotherapy. Clinical genitourinary cancer, . https://doi.org/10.1016/j.clgc.2021.11.010
Abuhelwa, Ahmad Y, et al. "Enhanced Bellmunt Risk Score for Survival Prediction in Urothelial Carcinoma Treated With Immunotherapy." Clinical genitourinary cancer vol. (2021). doi: https://doi.org/10.1016/j.clgc.2021.11.010
Abuhelwa AY, Bellmunt J, Kichenadasse G, McKinnon RA, Rowland A, Sorich MJ, Hopkins AM. Enhanced Bellmunt Risk Score for Survival Prediction in Urothelial Carcinoma Treated With Immunotherapy. Clin Genitourin Cancer. 2021 Dec 02; doi: 10.1016/j.clgc.2021.11.010. Epub 2021 Dec 02. PMID: 34953754.
Copy Download .nbib Format: NLM
SARS-CoV-2 vaccination may help patients with persistent COVID-19 smell dysfunction.

Ear, nose, & throat journal

Lechien JR, Hopkins C, Vaira LA, Saussez S.
PMID: 34569299
Ear Nose Throat J. 2021 Sep 26;1455613211044770. doi: 10.1177/01455613211044770. Epub 2021 Sep 26.

No abstract available.

Cite
Lechien JR, Hopkins C, Vaira LA, et al. SARS-CoV-2 vaccination may help patients with persistent COVID-19 smell dysfunction. Ear Nose Throat J. 2021;1455613211044770doi: 10.1177/01455613211044770.
Lechien, J. R., Hopkins, C., Vaira, L. A., & Saussez, S. (2021). SARS-CoV-2 vaccination may help patients with persistent COVID-19 smell dysfunction. Ear, nose, & throat journal, 1455613211044770. https://doi.org/10.1177/01455613211044770
Lechien, Jerome R, et al. "SARS-CoV-2 vaccination may help patients with persistent COVID-19 smell dysfunction." Ear, nose, & throat journal vol. (2021): 1455613211044770. doi: https://doi.org/10.1177/01455613211044770
Lechien JR, Hopkins C, Vaira LA, Saussez S. SARS-CoV-2 vaccination may help patients with persistent COVID-19 smell dysfunction. Ear Nose Throat J. 2021 Sep 26;1455613211044770. doi: 10.1177/01455613211044770. Epub 2021 Sep 26. PMID: 34569299.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 326 entries